Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,770,328 papers from all fields of science
Search
Sign In
Create Free Account
MLN-518
Known as:
CT-53518
, CT53518
, MLN518
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
tandutinib
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
FLT 3 Inhibitors for the Treatment of Acute Myeloid Leukemia
P. Wiernik
2013
Corpus ID: 37118967
634. 42. Hexner EO, Serdikoff C, Jan M, et al. Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and…
Expand
2013
2013
pharmacodynamics myelodysplastic syndrome: safety, pharmacokinetics, and antagonist, in patients with acute myelogenous leukemia or high-risk Phase 1 clinical results with tandutinib (MLN518), a…
S. Sheng
,
N. Holford
,
+12 authors
R. Paquette
2013
Corpus ID: 78562373
2013
2013
increases sensitivity to MLN518 RNAi induced downregulation of FLT3 expression in AML cell lines
D. K. Walters
,
Eric P. Stoffregen
,
M. Heinrich
,
M. Deininger
,
B. Druker
2013
Corpus ID: 81833048
2013
2013
malignant hematopoiesis Effects of MLN518, a dual FLT3 and KIT inhibitor, on normal and
L. McGreevey
,
Andrea Haley
,
+5 authors
M. Heinrich
2013
Corpus ID: 87629756
2010
2010
Abstract 5781: ITRI-260, a new azaazulenone class kinase inhibitor, induces complete tumor regression and prolongs survival in AML mice
On Lee
,
Hsingjin-Eugene Liu
,
+10 authors
Chrong-Shiong Hwang
2010
Corpus ID: 71799591
The FMS-like tyrosine kinase-3 (FLT3) is a receptor tyrosine kinase with important roles in hematopoietic stem/progenitor cell…
Expand
2005
2005
Expediting Oncology Drug Approvals: The Public Backlash Against the FDA and Opportunities to Reform
Andrew J. Sung
2005
Corpus ID: 74628187
The FDA has made great strides over the past twenty years in loosening drug approval regulations to speed important, life-saving…
Expand